Market research
234080.KO JW Lifescience Corporation
KO KRW Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 172B
- P/E ratio
- Not available
- Analyst target
- 18000
- Dividend yield
- 5.0%
- Beta
- 0.23
Community
Investor discussion
1 comment
Sign in to join the 234080.KO discussion.
5 years, 5 months ago
JW Lifescience Corporation is currently in a long term downtrend where the price is trading 3.4% below its 200 day moving average.
From a valuation standpoint, the stock is 81.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.6.
JW Lifescience Corporation's total revenue rose by 0.2% to $45B since the same quarter in the previous year.
Its net income has dropped by 216.6% to $-6B since the same quarter in the previous year.
Finally, its free cash flow grew by 947.6% to $19B since the same quarter in the previous year.
Based on the above factors, JW Lifescience Corporation gets an overall score of 3/5.